• REV1–DHX36 Coordinates G-Quadruplex Replication

  2026-09-25

  A 2026 study shows that REV1 directly engages the G-quadruplex helicase DHX36, linking G4 unwinding to control of replication-associated single-stranded DNA gaps. The findings position REV1 as a coordinator of fork progression, mutagenesis, and cellular responses to G4 stabilization, while leaving open how these mechanisms translate to therapeutic settings.

• GSK126: An EZH2 Inhibitor for Mechanistic Studies

  2026-09-25

  Use GSK126 to test whether EZH2 catalytic activity contributes to a phenotype, then pair pharmacological inhibition with genetic perturbation and H3K27me3 readouts. A study of oxidant-stressed endothelial cells offers a practical model for extending this approach beyond oncology—while also showing why cross-domain conclusions need careful validation.

• TH287: MTH1 Inhibition and CRPC Radiosensitization

  2026-09-24

  TH287 is a potent MTH1 inhibitor used to investigate oxidized nucleotide handling and cancer-cell responses to DNA damage. In PC-3 and DU-145 castration-resistant prostate cancer models, a 2026 study reported greater cell killing with TH287 plus ionizing radiation than with either treatment alone, with the strongest effect when radiation was delivered 12 hours after drug treatment began.

• Pulmonary Risedronate–Vitamin D3 Dendrimers

  2026-09-24

  This study tested PAMAM-G5 dendrimers as a pulmonary co-delivery platform for risedronate sodium and vitamin D3, aiming to bypass limitations of oral dosing. In an osteoporosis rat model, inhaled treatment improved serum mineral measures and bone mineral density over 21 days, with molecular and metabolomic results implicating WNT signaling in disease progression and response.

• Bestatin and Actinonin Act Through Intracellular Effects

  2026-09-23

  Grujić and Renko found that bestatin and actinonin suppress proliferation of U937 and K562 cells in a manner not explained mainly by inhibition of cell-surface aminopeptidases. Efflux-modifier experiments support an intracellular component to their activity, and show that transporter effects can complicate interpretation of antiproliferative assays.

• (-)-Norepinephrine (+)-bitartrate Workflows

  2026-09-23

  Build dose-aware adrenergic signaling, cardiomyopathy, and cardiovascular assays with a fresh, light-protected workflow for (-)-Norepinephrine (+)-bitartrate. This guide separates clinical vasopressor conversion data from in vitro concentration design while providing practical preparation, application, and troubleshooting strategies.

• SOD2 mRNA-LNPs for Renal Ischemia–Reperfusion Injury

  2026-09-22

  This study identifies SOD2 as an enriched antioxidant cargo in mesenchymal stem cell extracellular vesicles and tests chemically modified SOD2 mRNA delivered by lipid nanoparticles as a defined alternative. In cell and mouse ischemia–reperfusion models, the treatment reduced reactive oxygen species and renal injury, supporting mitochondrial redox modulation as a promising but still preclinical strategy.

• Benzyl-activated Streptavidin Magnetic Beads for Capture

  2026-09-22

  Learn how to use Benzyl-activated Streptavidin Magnetic Beads for biotinylated protein, nucleic acid, and assay-target enrichment. The workflow also explains why annexin-V detection of early cardiomyocyte death should complement—not be confused with—bead-based ex vivo capture.

• G-1: Selective GPR30 Agonist Evidence

  2026-09-21

  G-1 is a selective GPR30 agonist with nanomolar receptor and cellular activity. Evidence supports its use in GPR30 activation in cardiovascular research, breast cancer migration assays, and mechanistic estrogen-receptor studies, while product specifications define its solvent and handling limits.

• Ziprasidone Augmentation in Anxious Depression

  2026-09-21

  This post-hoc moderator analysis examined whether baseline anxious depression altered the effects of ziprasidone added to escitalopram after incomplete SSRI response. Depression outcomes improved similarly in anxious and nonanxious subgroups, while the apparent anxiety benefit was small, statistically inconclusive, and not clinically meaningful.

• Wnt-C59: A Mechanistic Test for Wnt10a Flux

  2026-09-20

  Wnt-C59 is a potent PORCN inhibitor for testing whether Wnt ligand secretion drives β-catenin responses. This article connects exosomal Wnt10a biology with rigorous assay interpretation across osteogenesis and cancer biology.

• Bestatin, Actinonin, and Intracellular Antiproliferation

  2026-09-19

  Grujić and Renko showed that bestatin and actinonin suppress proliferation in hematologic cell models through mechanisms that cannot be explained by inhibition of cell-surface aminopeptidases alone. By using drug-efflux modifiers, the study linked intracellular drug accumulation and transporter activity to antiproliferative potency, providing a useful framework for interpreting verapamil effects in multidrug-resistance experiments.

• TH287 MTH1 Inhibitor for Radiosensitization

  2026-09-18

  TH287 converts oxidized nucleotide stress into a measurable cancer-cell vulnerability and offers a timing-sensitive strategy for studying radiosensitization. This guide translates recent CRPC findings into practical dosing, radiation, DNA-damage, apoptosis, and troubleshooting workflows.

• (S)-(+)-Ibuprofen Assay Workflows

  2026-09-18

  A scenario-based guide to using (S)-(+)-Ibuprofen, SKU B1018, in cell viability, proliferation, and cytotoxicity workflows. It connects COX inhibition, solvent handling, dose design, controls, and vendor selection to more interpretable assay data.

• Cycloastragenol in Glucocorticoid-Induced Osteonecrosis

  2026-09-17

  This 2024 in vivo study identifies excessive osteoclast activity as a modifiable component of methylprednisolone-induced osteonecrosis of the femoral head. In rats, cycloastragenol reduced necrotic changes, preserved trabecular bone, improved local blood supply, and suppressed osteoclastogenic and bone-resorption markers, supporting further investigation of osteoclast-directed hip-preservation strategies.

8680 records 1/579 page Next 12345 下5页 Last page